References
- Moeed A. Liver Enzymes and Non-Alcoholic Fatty Liver Disease: important Factors in Assessing Patterns of Clinical Management in Type-2 Diabetes Patients [Letter]. Diabetes Metab Syndr Obes. 2022;15:777–778. doi:10.2147/DMSO.S363684.eCollection2022
- Cefalu WT, Berg EG, Saraco M, et al. American Diabetes Association: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl.1):S15–S33. doi:10.2337/dc21-S002
- Gupta R, Lodha S, Sharma KK, et al. Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2. BMJ Open Diabetes Res Care. 2016;4(1):e000275. doi:10.1136/bmjdrc-2016-000275
- Bideberi AT, Mutagaywa R. Statin Prescription Patterns and Associated Factors Among Patients with Type 2 Diabetes Mellitus Attending Diabetic Clinic at Muhimbili National Hospital, Dar Es Salaam, Tanzania. Diabetes, Metab Syndr Obes Targets Ther. 2022;15:633‐646. doi:10.2147/DMSO.S347765
- AlGhamdi TS. Statins for Patients with Non-Alcoholic Fatty Liver Disease. J Endocrinol Metab. 2020;10(6):162–166. doi:10.14740/jem705